190 related articles for article (PubMed ID: 16955442)
1. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
Athey RJ; Walker RW
Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
[TBL] [Abstract][Full Text] [Related]
2. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
Athey RJ; Porter RW; Walker RW
Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
[TBL] [Abstract][Full Text] [Related]
3. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
Kessels RP; Mimpen G; Melis R; Rikkert MG
Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
[TBL] [Abstract][Full Text] [Related]
6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
7. Apathy may herald cognitive decline and dementia in Parkinson's disease.
Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
[TBL] [Abstract][Full Text] [Related]
8. [Executive function in Parkinson's disease].
Kanazawa A; Mizuno Y; Narabayashi H
Rinsho Shinkeigaku; 2001; 41(4-5):167-72. PubMed ID: 11676156
[TBL] [Abstract][Full Text] [Related]
9. Utility of TICS-M for the assessment of cognitive function in older adults.
de Jager CA; Budge MM; Clarke R
Int J Geriatr Psychiatry; 2003 Apr; 18(4):318-24. PubMed ID: 12673608
[TBL] [Abstract][Full Text] [Related]
10. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
11. Defining mild cognitive impairment in Parkinson's disease.
Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
[TBL] [Abstract][Full Text] [Related]
12. The rate of cognitive decline in Parkinson disease.
Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
[TBL] [Abstract][Full Text] [Related]
13. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
Int J Geriatr Psychiatry; 2003 Nov; 18(11):1043-9. PubMed ID: 14618557
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
Janvin CC; Larsen JP; Aarsland D; Hugdahl K
Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
[TBL] [Abstract][Full Text] [Related]
17. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
[TBL] [Abstract][Full Text] [Related]
18. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
Sabbagh MN; Silverberg N; Bircea S; Majeed B; Samant S; Caviness JN; Reisberg B; Adler CH
Parkinsonism Relat Disord; 2005 Aug; 11(5):311-5. PubMed ID: 15886042
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
Verleden S; Vingerhoets G; Santens P
Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
[TBL] [Abstract][Full Text] [Related]
20. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
